A. Buğra Ortaakarsu is a medicinal chemist and researcher with a strong focus on molecular modeling, particularly in molecular dynamics, protein dynamics, quantum chemistry, and density functional theory (DFT). As a member of Sigma Xi, The Scientific Research Honor Society, he is committed to advancing scientific knowledge through the rigorous investigation of chemical–protein interactions, with the goal of developing precise, physically grounded, and innovative analytical methodologies.

His research includes the study “Synthesis, Design, and Cholinesterase Inhibitory Activity of Novel 1,2,4-Triazole Schiff Bases: A Combined Experimental and Computational Approach,” which aims to identify promising therapeutic candidates for Alzheimer’s disease and other neurodegenerative disorders by integrating experimental findings with advanced computational techniques.

Adopting a highly interdisciplinary perspective, Ortaakarsu combines advanced mathematics, game theory, Riemannian geometry, and differential geometry to address complex scientific and strategic problems. By embedding game-theoretical principles into artificial intelligence frameworks, he develops optimized, adaptive systems applicable across diverse scientific and technological domains.

Driven by a strong commitment to scientific rigor and innovation, Ortaakarsu continues to design and refine novel methodologies at the intersection of medicinal chemistry, advanced geometry, computational modeling, quantum chemistry, and DFT, with a clear emphasis on translating theoretical insights into robust, real-world applications.